Zhang J - Search Results

1

Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib.

Zhang J, Johnson M, Barve M, Bazhenova L, McCarthy M, Schwartz R, Horvath-Walsh E, Velastegui K, Qian C, Spira A. Zhang J, et al. Oncologist. 2023 Apr 6;28(4):287-296. doi: 10.1093/oncolo/oyad051. Oncologist. 2023. PMID: 36892150 Free PMC article. Review.

2

Targeting interleukin-1β and inflammation in lung cancer.

Zhang J, Veeramachaneni N. Zhang J, et al. Biomark Res. 2022 Jan 27;10(1):5. doi: 10.1186/s40364-021-00341-5. Biomark Res. 2022. PMID: 35086565 Free PMC article. Review.

3

Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC.

Roller JF, Veeramachaneni NK, Zhang J. Roller JF, et al. Among authors: zhang j. Cancers (Basel). 2022 Jan 31;14(3):741. doi: 10.3390/cancers14030741. Cancers (Basel). 2022. PMID: 35159008 Free PMC article. Review.

4

Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies.

Batrash F, Shaik A, Rauf R, Kutmah M, Zhang J. Batrash F, et al. Among authors: zhang j. Cancers (Basel). 2024 Mar 10;16(6):1113. doi: 10.3390/cancers16061113. Cancers (Basel). 2024. PMID: 38539448 Free PMC article. Review.

5

Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.

Liu B, Chau J, Dai Q, Zhong C, Zhang J. Liu B, et al. Among authors: zhang j. Cancers (Basel). 2022 Nov 2;14(21):5401. doi: 10.3390/cancers14215401. Cancers (Basel). 2022. PMID: 36358819 Free PMC article.

6

Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy.

Chau J, Zhang J. Chau J, et al. Among authors: zhang j. Int J Mol Sci. 2021 Jul 23;22(15):7900. doi: 10.3390/ijms22157900. Int J Mol Sci. 2021. PMID: 34360663 Free PMC article. Review.

7

The Microbiome-TIME Axis: A Host of Possibilities.

Ross TJ, Zhang J. Ross TJ, et al. Among authors: zhang j. Microorganisms. 2023 Jan 22;11(2):288. doi: 10.3390/microorganisms11020288. Microorganisms. 2023. PMID: 36838253 Free PMC article. Review.

8

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.

Yan L, Tan Y, Chen G, Fan J, Zhang J. Yan L, et al. Among authors: zhang j. Int J Mol Sci. 2021 Sep 24;22(19):10268. doi: 10.3390/ijms221910268. Int J Mol Sci. 2021. PMID: 34638609 Free PMC article. Review.

9

IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer.

Huang C, Gan GN, Zhang J. Huang C, et al. Among authors: zhang j. J Hematol Oncol. 2020 Jun 5;13(1):69. doi: 10.1186/s13045-020-00898-y. J Hematol Oncol. 2020. PMID: 32503595 Free PMC article.

10

Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma.

Kutuk T, Walker JM, Ballo MT, Cameron RB, Alvarez JB, Chawla S, Luk E, Behl D, Dal Pra A, Morganstein N, Refaat T, Sheybani A, Squillante C, Zhang J, Kotecha R. Kutuk T, et al. Among authors: zhang j. Curr Oncol. 2023 May 23;30(6):5195-5200. doi: 10.3390/curroncol30060394. Curr Oncol. 2023. PMID: 37366877 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178,058 results

Search Page

Filters